As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations.
The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, Medicare director Meena Seshamani, and FDA Center for Drug Evaluation and Research director Patrizia Cavazzoni have retired or intend to retire prior to Trump's inauguration on Jan. 20.
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current transition team, has died at 65. | Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current transition team,
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and Medicaid Innovation at CMS.
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but expensive weight-loss drugs.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
Turquoise Health is a healthcare pricing platform that has raised over $55 million Vator · Joe Wisniewski, AVP of Channel Sales at Turquoise Health, on the VatorNews podcast In 2025, we may see radical top-down changes to our healthcare system as new heads of the NIH - National Institutes of Health,
Trump’s pick to lead HHS is facing 175 questions from Elizabeth Warren, skepticism from Mike Pence and delays related to his disclosure forms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback